Since 2004, it has been producing radiopharmaceuticals for PET/CT tests in its state-of-the-art facilities, which are seen as a reference point by the European Community of radiopharmaceuticals and are frequently visited by researchers, trainees and students for the purposes of their post-graduate studies.
In 2011, the company upgraded its facilities, thus
increasing the range of the radiopharmaceuticals it can manufacture
and the volume of productions on a daily basis.
The main features of the technological investments
realized by BIOKOSMOS since 2000 are as follows: